Coping and risk perception during the COVID-19 pandemic in type 2 diabetes: Does it influence metabolic control?

• Published in: PLOS global public health Vol. 4; no. 2; p. e0002793
• Main Authors: Alcántara-Garcés, María Teresa, Rodríguez-Ramírez, Alejandra Monserrat, García-Ulloa, Ana Cristina, García-Alanis, Mario, Martínez-Reyes, Gabriela Nazareth, Del Moral Vidal, Lupita Paola, Arizmendi-Rodríguez, Rodrigo Eduardo, Hernández-Jiménez, Sergio, Almeda-Valdes, Paloma
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 2024; Public Library of Science (PLoS)
• Subjects: Biology and life sciences; Medicine and Health Sciences
• ISSN: 2767-3375; 2767-3375
• DOI: 10.1371/journal.pgph.0002793

Diabetes and poor glycemic control are significant predictors of severity and death in the COVID-19 disease. The perception of this risk in individuals with type 2 diabetes (T2D) could modify coping styles, leading to behaviors associated with better self-care and metabolic control. Theoretically, active coping is associated with better glycemic control in patients with T2D. Nonetheless, information during extreme risk like the COVID-19 pandemic is still limited. Our objective was to evaluate the association between coping styles and risk perception in the COVID-19 pandemic and the change in metabolic parameters. This is a prospective study that included individuals with T2D treated in a tertiary care center during the COVID-19 outbreak who returned to follow-up one year later. We assessed coping styles and risk perception with the Extreme Risk Coping Scale and the risk perception questionnaire. Clinical characteristics and metabolic parameters were registered in both visits. Groups were compared using Kruskal Wallis tests, and changes in metabolic parameters were assessed with Wilcoxon rank sum tests. Our sample included 177 participants at baseline, and 118 concluded the study. Passive coping was more frequent in women. Low-risk perception was associated with higher age, lower psychiatric comorbidities, and lower frequency of psychiatric treatment compared with other risk perception groups. Patients with active coping plus high-risk perception did not have a change in metabolic parameters at follow-up, whereas patients with other coping styles and lower risk perception had an increase in total cholesterol, LDL-cholesterol, and triglycerides. There were no differences by coping group or by risk perception in glycemic control.